Table 3 Patient characteristics from the literature review (see text for details)
From: Unprovoked internal jugular vein thrombosis: a case report and literature review
Median age | 51 years old (16–88 y.o.) |
Sex | F: 26/48 (54.2%) |
M: 16/48 (33.3%) | |
Unknown: 6/48 (12.5%) | |
Number of countries | 17 |
Modality of diagnostic imaging | US: 7/48 (14.6%) |
CT: 11/48 (22.9%) | |
US + CT: 19/48 (39.5%) | |
US + MRI: 2/48 (4.2%) | |
US + CT + MRI: 2/48 (4.2%) | |
Other or unknown modality: 7/48 (14.6%) | |
Type of treatment | Heparin only: 7/40 (17.5%) |
Heparin + oral anticoagulant: 19/40 (47.5%) | |
Oral anticoagulant only: 3/40 (7.5%) | |
Other or unknown: 11/40 (27.5%) | |
Type of oral anticoagulant | Vitamin K antagonists: 18/22 (81.8%) |
Direct oral anticoagulants: 3/22 (13.6%) | |
Unknown: 1/22 (4.6%) | |
Treatment duration | 3 months: 3/48 (6.25%) |
6 months: 3/48 (6.25%) | |
Long-term: 5/48 (10.4%) | |
Other: 4/48 (8.3%) | |
Unknown: 33/48 (68.8%) | |
Complications | Pulmonary embolism: 3/48 (6.25%) |
Neurological complication: 0/48 (0%) | |
Recurrent thrombosis: 2/48 (4.15%) | |
Extension of thrombosis: 1/48 (2.1%) | |
No complication: 42/48 (87.5%) |